Author

Zaher Mutaz Ashour

Institution: Hashemite University

Observed institution: Hashemite University

ORCID: 0009-0006-1450-2476

Observed ORCID: 0009-0006-1450-2476

OpenAlex ID: A5119438726

Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials

2026 · Zaher Mutaz Ashour, Mus’ab Theeb Mustafa, et al. · Figshare

Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials

2026 · Zaher Mutaz Ashour, Mus’ab Theeb Mustafa, et al. · Expert Opinion on Drug Safety

Abstract 3787: The safety of PARP inhibitors combined with immune checkpoint inhibitors versus immune checkpoint inhibitor monotherapy: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials

2026 · Mus'ab Theeb Mustafa, Aws Khalid Abushanab, et al. · Cancer Research

Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials

2025 · Zaher Mutaz Ashour, Aws Khalid Abushanab, et al. · Journal of Oncology Pharmacy Practice

Works count: 4

Citation count:

H-index:

I10-index: